Jan L Hillson M.D.

Jan L Hillson MD is a highly experienced medical professional currently serving as a Partner at Cascadia Drug Development Group and Interim Chief Medical Officer at GlycoEra AG, both since February 2024. Additionally, Jan L Hillson is a member of the Board of Directors at Eledon Pharmaceuticals, Inc., contributing to the Science Committee. Prior roles include Senior Vice President of Clinical Development at ProventionBio, where Jan L Hillson led significant programs in Type 1 Diabetes, Systemic Lupus, and Celiac Disease, and at Alpine Immune Sciences, Inc. as Senior Vice President of Clinical Development. Previous experience includes leadership positions at ChemoCentryx, Momenta Pharmaceuticals, ZymoGenetics, Xcyte Therapies, and Virginia Mason Medical Center, encompassing clinical development, translational research, and rheumatology. Educational qualifications include a Doctor of Medicine from Stanford University School of Medicine, residency and fellowship at the University of Washington, and master's degrees from Caltech and UC San Diego.